Abstract
Background: Extended Spectrum β-lactamases (ESBLs) are enzymes produced by some bacteria that inactivate oxyimino-cephalosporins, a class of β-lactam antibiotics family. They are mainly encoded by the β-lactamase gene families TEM, SHV and CTX-M. The Enterobacteriaceae expressing these genes, in particular Escherichia coli are widely expanded in the world with different prevalence rate from one region to another. The objective of this study, carried out from strains isolated at the National Institute of Hygiene (INH) in Togo, was to (i) detect and characterize the genes involving in the production of β-lactamase among E. coli strains and (ii) evaluate their prevalence. Methodology: From May 2013 to July 2015, 91 E. coli strains resistant to third generation cephalosporins (C3G) were collected from several specimens and analyzed for the detection of β-lactamase resistance genes, blaTEM, blaSHV and blaCTX-M by simplex and multiplex PCR. Results: The E. coli strains resistant at least to one third generation cephalosporin, were isolated from urine 58/91 (63.74%), vaginal samples 17/91 (17.68%), wound swabs 7/91 (7.69%), 4/91 semen samples (4.40%), urethral curettage CU 2/91 (2.20%), sputum 1/91 (1.1%), stool 1/91 (1.1%) and joint fluid 1/91 (1.1%). Resistance to third generation cephalosporins was associated with a resistance to quinolone (96.67%), trimethoprim/sulfamethoxazole (94.44%), gentamicin (75.82%) and chloramphenicol (59.09%). ESBL genes were present in all E. coli strains with the following proportions: TEM/CTX-M1 52/91 (57.14%), TEM/SHV/CTX-M1 19/91 (20.88%), CTX-M 18/91 (19.78%), TEM 1/91 (1.10%) and TEM/SHV 1/91 (1.10%). Conclusion: The presence of ESBL producing E. coli is a reality in Togo and their wide dissemination compromises the treatment of classical infections such as urinary tract infection, bacterial pneumonia, sepsis or meningitis. The acquisition of molecular data on bacterial resistance to antibiotics is necessary for better therapeutic management of these infections. This is a first determination of the β-lactamase genes in Togo.
Highlights
Extended Spectrum β-lactamases (ESBLs) are enzymes produced by some bacteria that inactivate oxyimino-cephalosporins, a class of β-lactam antibiotics family
extended spectrum betalactamase (ESBL) genes were present in all E. coli strains with the following proportions: TEM/CTX-M1 52/91 (57.14%), TEM/SHV/CTX-M1 19/91 (20.88%), CTX-M 18/91 (19.78%), TEM 1/91 (1.10%) and TEM/SHV 1/91 (1.10%)
The findings revealed a low presence of ESBL genes alone 19/91 (20.88%) in contrast to percentage of associations, 72/91 (79.21%) E. coli strains harbored more than one ESBL resistance gene
Summary
Extended Spectrum β-lactamases (ESBLs) are enzymes produced by some bacteria that inactivate oxyimino-cephalosporins, a class of β-lactam antibiotics family. They are mainly encoded by the β-lactamase gene families TEM, SHV and CTX-M. The Enterobacteriaceae expressing these genes, in particular Escherichia coli are widely expanded in the world with different prevalence rate from one region to another. The objective of this study, carried out from strains isolated at the National Institute of Hygiene (INH) in Togo, was to (i) detect and characterize the genes involving in the production of β-lactamase among E. coli strains and (ii) evaluate their prevalence
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
